Literature DB >> 15522326

The role of thrombospondin-1 in human disease.

Nowokere Esemuede1, Taeseung Lee, Daphne Pierre-Paul, Bauer E Sumpio, Vivian Gahtan.   

Abstract

Thrombospondin-1 (TSP-1) is a large matricellular glycoprotein secreted by many cell types. It is a component of the extracellular matrix during active and subacute processes. Due to TSP-1's ability to interact with a variety of matrix proteins and cell-surface receptors, controversy exists about its conflicting functions. In this review, we will discuss the role of TSP-1 in human disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522326     DOI: 10.1016/j.jss.2004.05.015

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  44 in total

Review 1.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

2.  Pregnancy-associated genes contribute to antiluteolytic mechanisms in ovine corpus luteum.

Authors:  Jared J Romero; Alfredo Q Antoniazzi; Natalia P Smirnova; Brett T Webb; Fang Yu; John S Davis; Thomas R Hansen
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

3.  Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration.

Authors:  Imran A Bhutto; Koichi Uno; Carol Merges; Lei Zhang; D Scott McLeod; Gerard A Lutty
Journal:  Arch Ophthalmol       Date:  2008-05

4.  Induction of vascular endothelial growth factor and matrix metalloproteinase-9 via CD47 signaling in neurovascular cells.

Authors:  Changhong Xing; Ken Arai; Kyung-Pil Park; Eng H Lo
Journal:  Neurochem Res       Date:  2010-04-03       Impact factor: 3.996

Review 5.  Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.

Authors:  Jie Ma; David J Waxman
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

6.  Myeloid-specific deletion of thrombospondin 1 protects against inflammation and insulin resistance in long-term diet-induced obese male mice.

Authors:  Hasiyet Memetimin; Dong Li; Kaiyuan Tan; Changcheng Zhou; Ying Liang; Yadi Wu; Shuxia Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-10-23       Impact factor: 4.310

Review 7.  Adipocytokines and the metabolic complications of obesity.

Authors:  Neda Rasouli; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

8.  Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension.

Authors:  Cristhiaan D Ochoa; Lunyin Yu; Essam Al-Ansari; Charles A Hales; Deborah A Quinn
Journal:  J Cardiothorac Surg       Date:  2010-05-04       Impact factor: 1.637

9.  Sex-related differences in gene expression following Coxiella burnetii infection in mice: potential role of circadian rhythm.

Authors:  Julien Textoris; Leang Heng Ban; Christian Capo; Didier Raoult; Marc Leone; Jean-Louis Mege
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

Review 10.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.